Spirometry is a standard test doctors use to determine how well your lungs function. A score that measures airflow into and out of your lungs can help diagnose COPD and determine the best treatments.

What Are Pulmonary Function Tests (PFTs)? Pulmonary function tests (PFTs) are lung tests. They show how well your lungs work. They’re noninvasive, which means that the doctor doesn’t cut you or put ...

A spirometry is a pulmonary function test that measures how much air a person breathes out, and how quickly. Pulmonary function tests measure how well the lungs are working. It is an office-based ...

An incentive spirometer is a handheld medical device that measures the volume of your breath. Your doctor, surgeon, or nurse will give you specific instructions on how to use it. Share on Pinterest ...

Collecting spirometry data remotely is done with a combination of a Bluetooth-enabled, handheld spirometer and an accompanying smartphone app that enables data collection and streaming of test results ...

Any patient who smokes one or more cigarettes per day will be considered an active smoker. The criteria for the diagnosis of COPD is a post-bronchodilator FEV1/FVC ratio of < 70% (absolute value).

Spirometry is the only recognized method of definitively diagnosing chronic obstructive pulmonary disease (COPD). 1 It also gives patients and physicians a reliable way of tracking the progression of ...

Please provide your email address to receive an email when new articles are posted on . Many general practitioners need help interpreting spirometry. An AI-based software had 88% diagnostic accuracy ...

According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the ...

Spirometry is a common pulmonary function test that measures how well a person moves air in and out of the lungs. Workers who inhale some types of dusts, gases or other air contaminants can, over time ...

Home spirometry shows potential for early detection of pulmonary function decline in patients with systemic sclerosis–associated interstitial lung disease (SSc-ILD). It shows good cross-sectional ...

In 2008, as part of the changes to develop integrated health care services in the Canterbury region of New Zealand, the local health board in collaboration with general practitioners, respiratory ...